Einloggen

Thematische Bibliographien / Coronary heart disease / Zeitschriftenartikel

Zeitschriftenartikel zum Thema „Coronary heart disease“

Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Coronary heart disease.

Autor: Grafiati

Veröffentlicht am 4. Juni 2021

Zuletzt aktualisiert am 29. Juli 2024

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Coronary heart disease" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Nurmamadovna, Ishankulova Nasiba. „Coronary Heart Disease“. American Journal of Medical Sciences and Pharmaceutical Research 03, Nr. 02 (28.02.2021): 31–36. http://dx.doi.org/10.37547/tajmspr/volume03issue02-04.

Der volle Inhalt der Quelle

Annotation:

The article covers the etiology, pathogenesis, classification, diagnosis, clinical picture and treatment of coronary heart disease, provides a literature review. Cardiovascular disease (CVD) represents the leading cause of death among women as well as men. The number of deaths due to CVD in women are greater than in men. There are significant gender-related differences concerning CVD.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Shakhnoza, Iskandarova, und Amilova Asalya. „PREVENTION OF CORONARY HEART DISEASE“. American Journal of Medical Sciences and Pharmaceutical Research 04, Nr. 04 (01.04.2022): 19–21. http://dx.doi.org/10.37547/tajmspr/volume04issue04-05.

Der volle Inhalt der Quelle

Annotation:

Primary prevention, based on healthy lifestyle habits that prevent the emergence of risk factors, is the preferred method of reducing cardiovascular risk. Reducing the prevalence of obesity is the most urgent task, and it is pleiotropic in that it affects blood pressure, lipid profile, glucose metabolism, inflammation, progression of atherothrombotic disease. Physical activity also improves several risk factors, with the added potential to lower heart rate.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Sudhakar, B. G. K. „Structural heart disease interventions“. Clinical Research and Clinical Trials 3, Nr. 5 (25.06.2021): 01–05. http://dx.doi.org/10.31579/2693-4779/042.

Der volle Inhalt der Quelle

Annotation:

Seed for invasive cardiology was sown in early part of nineties. Cardiac catheterization was actually pioneered by Werner Forssmann in 1929. However, credit for therapeutic interventional cardiology should go to US vascular radiologist, Charles Theodore Dotter for performing first peripheral arterial angioplasty [PTA] in 1964. Subsequently, a German cardiologist by name Andreas Gruentzig adapted the technique in 1974 to suit coronary artery disease and performed the first human coronary balloon angioplasty to treat blockage in coronary artery in 1977.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

Windecker, S. „CORONARY DISEASE: Intervention in coronary artery disease“. Heart 83, Nr. 4 (01.04.2000): 481–90. http://dx.doi.org/10.1136/heart.83.4.481.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

Gulnara, Asadova, und Djamalov Abdurakhman. „REMEDIES AND RECOMMENDATIONS CORONARY HEART DISEASES“. Eurasian Journal of Medical and Natural Sciences 03, Nr. 02 (01.02.2023): 224–28. http://dx.doi.org/10.37547/ejmns-v03-i02-p1-37.

Der volle Inhalt der Quelle

Annotation:

Prevention of coronary heart disease is a series of complex measures aimed at preventing the onset of the disease, the development and occurrence of possible (predictable) complications, which can be even fatal. Prevention of coronary heart disease is indicated for both sick people and healthy people who are at risk of developing the disease. Patients diagnosed with coronary heart disease are shown non-drug treatment, which is a complete or partial elimination of risk factors. Risk factors are any predisposing factors that increase the likelihood of developing or worsening a disease. Risk factors for coronary heart disease are fundamentally divided into removable and non-removable.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Jha, Dr Sudha, Dr Naved Ahmad, Dr Surya Kant Nagtilak und Dr Maheshwar Chawla. „Coronary Heart Disease, A Gift of Modern Civilization“. International Journal of Scientific Research 2, Nr. 11 (01.06.2012): 378–80. http://dx.doi.org/10.15373/22778179/nov2013/122.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

Timmis, A. „Coronary disease: Acute coronary syndromes: risk stratification“. Heart 83, Nr. 2 (01.02.2000): 241–46. http://dx.doi.org/10.1136/heart.83.2.241.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Gulyabin, Konstantin Robertovich. „Coronary heart disease“. Spravočnik vrača obŝej praktiki (Journal of Family Medicine), Nr. 1 (2022): 63–66. http://dx.doi.org/10.33920/med-10-2201-09.

Der volle Inhalt der Quelle

Annotation:

Coronary heart disease is of great clinical importance in medical practice. The development of medical science makes it possible to introduce new modern methods of treating this disease. One of these is coronary artery bypass grafting, a modern method of treating coronary heart disease, which allows to reliably increase myocardial perfusion and prolong the life expectancy of patients with coronary heart disease.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Lavie, Carl J., Gary Legwold und Michael E. DeBakey. „Coronary heart disease“. Postgraduate Medicine 102, Nr. 2 (August 1997): 210–15. http://dx.doi.org/10.3810/pgm.1997.08.285.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

Williams, Samantha. „Coronary heart disease“. Nursing Standard 19, Nr. 51 (31.08.2005): 67–68. http://dx.doi.org/10.7748/ns.19.51.67.s58.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

11

Ahmed, Munir. „CORONARY HEART DISEASE;“. Professional Medical Journal 21, Nr. 06 (10.12.2014): 1171–73. http://dx.doi.org/10.29309/tpmj/2014.21.06.2250.

Der volle Inhalt der Quelle

Annotation:

Objective: This study was done to find any correlation among total cholesterol, triglycerides, low density lipoprotein cholesterol and high density lipoprotein cholesterol estimated in serum of offsprings of coronary heart disease patients. Study Design: A cross sectional comparative study. Patients and Methods: Two hundred and fifty (250) subjects having parents with coronary heart disease were selected from Punjab Institute of Cardiology Lahore. The serum total cholesterol, triglycerides, low density lipoprotein cholesterol, and high density lipoprotein cholesterol were estimated. Coefficient of variation was calculated to find whether observations in one series vary correspondingly with observations in another series. Results: Highly significant positive correlation was found between total cholesterol and triglycerides, and, total cholesterol and low density lipoprotein cholesterol. Highly significant negative correlation was found between low density lipoprotein cholesterol and high density lipoprotein cholesterol. Correlation between TG and LDL-c was also significant. Conclusions: Serum total cholesterol, triglycerides, low density lipoprotein cholesterol and high density lipoprotein cholesterol have strong association with one and other. For prediction, prevention and management of coronary heart disease it is important to estimate and observe the correlation among these parameters.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

12

AHMED, MUNIR, und MOHAMMAD TAYYIB. „CORONARY HEART DISEASE“. Professional Medical Journal 16, Nr. 01 (10.03.2009): 87–93. http://dx.doi.org/10.29309/tpmj/2009.16.01.2988.

Der volle Inhalt der Quelle

Annotation:

O b j e c t i v e s : This study was conducted to perform serum lipid profile in off springs of premature coronary heart disease(CHD) patients and age and sex matched normal controls and compare the results of two groups. S t u d y d e s i g n : A cross sectional study.Patients a n d m e t h o d s : 250 off springs of diagnosed premature CHD patients were selected from Punjab institute of cardiology, Lahoreand Services hospital, Lahore. 50 age and sex matched normal controls were selected from different areas of Lahore. Serum totalcholesterol (TC), serum triglycerides (TG) serum low density lipoprotein-cholesterol (LDC-c) and serum high density lipoprotein cholesterol(HDL-c) was performed. Results: Serum TC, TG, LDL-c of off springs of premature CHD patients was increased as compared with normalcontrols. Serum HDL-c of all the subjects of off springs of premature CHD patients was decreased as compared with normal controls.C o n c l u s i o n : Off springs of premature CHD patients are more prone to develop lipid abnormalities as compared with normal controls.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

13

GILANi, MUHAMMAD SHAH. „CORONARY HEART DISEASE“. Professional Medical Journal 15, Nr. 02 (10.03.2008): 255–59. http://dx.doi.org/10.29309/tpmj/2008.15.02.2759.

Der volle Inhalt der Quelle

Annotation:

Objective: To assess the value of coronary events reflected by changesin R-wave amplitude after exercise.Setting: Nishtar Hospital, Multan. Duration. One year. Study Design: comparativestudy.Material and Methods: Sample size 146 patients.Sampling Technique: Convenient probability sampling done.Results: All patients were followed up for 6 months, during which time myocardial infarction and death of cardiovascularorigin were considered endpoints. The incidence of events in patients in whom R-wave amplitude decreased (normalresponse) and in those in whom R-wave amplitude did not change or increase (abnormal response) was compared.The incidence of coronary events in patients with a normal response was 23% and in those with an abnormal response,45.8% (p<0.01). Correlating the results with several non invasive and angiographic variables, an abnormal R-waveresponse showed a significantly higher rate of events in the subsets of patients with prior myocardial infarction, absenceof cardiomegaly, maximal functional capacity lower than 4 METs, maximal heart rate higher than 140 beats/min andabnormal left ventricular function. Conclusion: The changes in R-wave amplitude after exercise is a variable thatshould be taken into account when assessing the risk of future events in patients with coronary heart disease.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

14

Smith, Timothy W., und Arthur S. Leon. „Coronary Heart Disease“. Journal of Cardiopulmonary Rehabilitation 14, Nr. 3 (Mai 1994): 201. http://dx.doi.org/10.1097/00008483-199405000-00013.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

15

Emery, Charles F. „Coronary Heart Disease“. Journal of Cardiopulmonary Rehabilitation 14, Nr. 3 (Mai 1994): 201. http://dx.doi.org/10.1097/00008483-199405010-00013.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

16

Smith, T. W., A. S. Leon und Robert G. McMurray. „Coronary Heart Disease“. Medicine & Science in Sports & Exercise 26, Nr. 1 (Januar 1994): 118. http://dx.doi.org/10.1249/00005768-199401000-00023.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

17

Lutz, Wolfgang. „CORONARY HEART DISEASE“. Nutrition Today 21, Nr. 2 (März 1986): 40. http://dx.doi.org/10.1097/00017285-198603000-00007.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

18

Ellsworth, DarrellL, Phyliss Sholinsky, Cashell Jaquish, RichardR Fabsitz und TeriA Manolio. „Coronary heart disease:“. American Journal of Preventive Medicine 16, Nr. 2 (Februar 1999): 122–33. http://dx.doi.org/10.1016/s0749-3797(98)00138-x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

19

Stewart, B. Fendley. „Coronary Heart Disease“. Physical Medicine and Rehabilitation Clinics of North America 6, Nr. 1 (Februar 1995): 37–53. http://dx.doi.org/10.1016/s1047-9651(18)30477-7.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

20

O’Rourke, Robert A., Kanu Chatterjee und Jeanne Y. Wei. „Coronary heart disease“. Journal of the American College of Cardiology 10, Nr. 2 (August 1987): 52A—56A. http://dx.doi.org/10.1016/s0735-1097(87)80449-7.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

21

Friesinger, Gottlieb C., und Thomas J. Ryan. „CORONARY HEART DISEASE“. Cardiology Clinics 17, Nr. 1 (Februar 1999): 93–122. http://dx.doi.org/10.1016/s0733-8651(05)70059-x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

22

Bishop, Tina. „Coronary heart disease“. Primary Health Care 26, Nr. 5 (26.05.2016): 14. http://dx.doi.org/10.7748/phc.26.5.14.s18.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

23

Cook, Rosemary. „Coronary heart disease“. Primary Health Care 6, Nr. 6 (Juni 1988): 25–30. http://dx.doi.org/10.7748/phc.6.6.23.s11.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

24

Robinson, Karen. „Coronary heart disease“. Emergency Nurse 9, Nr. 7 (November 2001): 29–34. http://dx.doi.org/10.7748/en2001.11.9.7.29.c1376.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

25

Augustin, Joi, und Johanna Dwyer. „Coronary heart disease“. Topics in Clinical Nutrition 10, Nr. 1 (Dezember 1994): 1–13. http://dx.doi.org/10.1097/00008486-199410010-00003.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

26

&NA;. „CORONARY HEART DISEASE“. Nursing 19, Nr. 1 (Januar 1989): 97–99. http://dx.doi.org/10.1097/00152193-198901000-00031.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

27

Tunstall-Pedoe, H. „Coronary heart disease.“ BMJ 303, Nr. 6804 (21.09.1991): 701–4. http://dx.doi.org/10.1136/bmj.303.6804.701.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

28

McMurray, J., und H. J. Dargie. „Coronary heart disease.“ BMJ 303, Nr. 6816 (14.12.1991): 1546–47. http://dx.doi.org/10.1136/bmj.303.6816.1546-a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

29

Poole-Wilson, P. A., und G. Sutton. „Coronary heart disease.“ BMJ 304, Nr. 6825 (22.02.1992): 504–5. http://dx.doi.org/10.1136/bmj.304.6825.504-b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

30

Davies, M. J. „CORONARY DISEASE: The pathophysiology of acute coronary syndromes“. Heart 83, Nr. 3 (01.03.2000): 361–66. http://dx.doi.org/10.1136/heart.83.3.361.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

31

Gershlick, A. H. „CORONARY DISEASE: Role of stenting in coronary revascularisation“. Heart 86, Nr. 1 (01.07.2001): 104–12. http://dx.doi.org/10.1136/heart.86.1.104.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

32

JURGENSEN, J. S. „Severe aneurysmal coronary artery disease“. Heart 86, Nr. 4 (01.10.2001): 404. http://dx.doi.org/10.1136/heart.86.4.404.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

33

Fox, K. A. A. „CORONARY DISEASE: Acute coronary syndromes: presentation---clinical spectrum and management“. Heart 84, Nr. 1 (01.07.2000): 93. http://dx.doi.org/10.1136/heart.84.1.93.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

34

Rahman, M., A. Sumin und A. Ankudinov. „СОСТОЯНИЕ КОРОНАРНОГО РУСЛА ПРИ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА У ПАЦИЕНТОВ С ГИПОТИРЕОЗОМ“. Baikal Medical Journal 2, Nr. 4 (25.12.2023): 64–71. http://dx.doi.org/10.57256/2949-0715-2023-4-64-71.

Der volle Inhalt der Quelle

Annotation:

Hypothyroidism is a significant aggravating factor for coronary heart disease (CHD). However, there are no practical recommendations for the management of this group to date. The main method of assessing the severity of coronary artery disease is a morphological assessment of the condition of the coronary arteries. The aim. To carry out comparative assessment of clinical parameters, including the state of the coronary bed in patients with coronary artery disease with newly diagnosed (without hormone replacement therapy) and primary manifest hypothyroidism compared with patients with coronary artery disease without hypothyroidism. Materials and methods. Two hundred and forty patients with CHD were examined. The study group included 90 patients with coronary heart disease and hypothyroidism, the comparison group consisted of 150 patients with coronary artery disease without thyroid pathology. A comprehensive examination of patients, including coronary angiography, was performed. The frequency of cases and characteristics of lesions of the coronary bed, the volume of interventions were assessed. The analysis of the obtained data was carried out in Statistica 10.0 (StatSoft Inc., USA). Results. In the study group (CHD and hypothyroidism), a statistically significantly increased level of myoglobin, a change in lipid profile parameters in relation to patients with CHD without hypothyroidism was found. In the group of patients with coronary artery disease and hypothyroidism, a predominance of the frequency of multivessel lesions of the coronary bed was revealed. The volume of surgical interventions between the examined patients did not reveal significant differences. Conclusion. Patients with coronary heart disease and hypothyroidism should be considered as a group of additional cardiovascular risk and require a more careful approach. It is possible to prescribe higher dosages of statins.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

35

Yakovleva, L. N. „Stable coronary heart disease“. Medicine of Ukraine, Nr. 4(230) (29.03.2019): 45–50. http://dx.doi.org/10.37987/1997-9894.2019.4(230).185661.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

36

Lee, I.-Min, Ralph S. Paffenbarger und Paul D. Thompson. „Preventing Coronary Heart Disease“. Physician and Sportsmedicine 29, Nr. 2 (Februar 2001): 37–52. http://dx.doi.org/10.3810/psm.2001.02.366.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

37

Omenn, Gilbert S., Shirley A. A. Beresford und Arno G. Motulsky. „Preventing Coronary Heart Disease“. Circulation 97, Nr. 5 (10.02.1998): 421–24. http://dx.doi.org/10.1161/01.cir.97.5.421.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

38

Jairath, N., und Anne Woods. „Managing coronary heart disease“. Dimensions of Critical Care Nursing 18, Nr. 5 (September 1999): 54. http://dx.doi.org/10.1097/00003465-199909000-00016.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

39

Jackson, Rod, John Lynch und Sam Harper. „Preventing coronary heart disease“. BMJ 332, Nr. 7542 (16.03.2006): 617–18. http://dx.doi.org/10.1136/bmj.332.7542.617.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

40

King, Kathryn M., und Heather M. Arthur. „Coronary Heart Disease Prevention“. Journal of Cardiovascular Nursing 18, Nr. 4 (September 2003): 274–81. http://dx.doi.org/10.1097/00005082-200309000-00006.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

41

Hayman, Laura L., und Patricia R. Reineke. „Preventing Coronary Heart Disease“. Journal of Cardiovascular Nursing 18, Nr. 4 (September 2003): 294–301. http://dx.doi.org/10.1097/00005082-200309000-00008.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

42

Ockene, I. S., und J. K. Ockene. „Preventing coronary heart disease“. Tobacco Control 2, Nr. 2 (01.06.1993): 165. http://dx.doi.org/10.1136/tc.2.2.165b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

43

Assaf, Annlouise R., Kate L. Lapane, Joyce L. McKenney, Sonja McKinlay und Richard A. Carleton. „Coronary heart disease surveillance“. Journal of Clinical Epidemiology 53, Nr. 4 (April 2000): 419–26. http://dx.doi.org/10.1016/s0895-4356(99)00183-3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

44

Thompson, GilbertR, Rossitza Naoumova, Paul Sidhu, Richard Underwood, PaulD Flynn, CarolA Seymour, DerekG Cook, F. Game und R. Neary. „Predicting coronary heart disease“. Lancet 343, Nr. 8898 (März 1994): 670–72. http://dx.doi.org/10.1016/s0140-6736(94)92664-6.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

45

Rose, Geoffrey, M. P. H. Doublet Stewart, ChristopherA Birt, PeterR Croft und PatrickF James. „CORONARY HEART DISEASE PREVENTION“. Lancet 332, Nr. 8619 (November 1988): 1081–82. http://dx.doi.org/10.1016/s0140-6736(88)90102-x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

46

Mccormick, JamesS, Petr Skrabanek, J. A. Lee und R. C. Cottrell. „CORONARY HEART DISEASE PREVENTION“. Lancet 332, Nr. 8621 (November 1988): 1189–90. http://dx.doi.org/10.1016/s0140-6736(88)90252-8.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

47

Henderson, Andrew. „Coronary heart disease: Overview“. Lancet 348 (November 1996): S1—S4. http://dx.doi.org/10.1016/s0140-6736(96)98001-0.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

48

Messerli, Franz H. „Ephemeral Coronary Heart Disease“. European Heart Journal 40, Nr. 24 (21.06.2019): 1906–8. http://dx.doi.org/10.1093/eurheartj/ehz400.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

49

Linden, B. „Coronary heart disease prevention“. Coronary Health Care 3, Nr. 2 (Mai 1999): 99–104. http://dx.doi.org/10.1016/s1362-3265(99)80022-4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

50

Linden, Belinda. „Coronary heart disease prevention“. Coronary Health Care 3, Nr. 1 (Februar 1999): 48–53. http://dx.doi.org/10.1016/s1362-3265(99)80034-0.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!